ERNA vs SLB · P/E 0.0, rev $582.0K vs P/E 12, rev $35.71B
Eterna Therapeutics Inc (ERNA) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the ERNA and SLB stock pages for the full models.
Not investment advice.